sc 53116 has been researched along with mosapride in 3 studies
| Studies (sc 53116) | Trials (sc 53116) | Recent Studies (post-2010) (sc 53116) | Studies (mosapride) | Trials (mosapride) | Recent Studies (post-2010) (mosapride) |
|---|---|---|---|---|---|
| 20 | 0 | 3 | 286 | 90 | 142 |
| Protein | Taxonomy | sc 53116 (IC50) | mosapride (IC50) |
|---|---|---|---|
| hepatocyte nuclear factor 4-alpha isoform 2 | Homo sapiens (human) | 4.18 | |
| perilipin-5 | Homo sapiens (human) | 1.315 | |
| perilipin-1 | Homo sapiens (human) | 1.196 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 1.2753 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.3966 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.4 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.7 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.6794 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 1 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.908 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.3966 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.8117 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 1 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.2959 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 4.7932 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.3056 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischmeister, R; Langlois, M | 1 |
| Fujiwara, I; Harada, H; Hirokawa, Y; Kato, S; Suzuki, K; Yoshida, N; Yoshikawa, T | 1 |
| Kamato, T; Miyata, K; Nagakura, Y; Yamano, M | 1 |
1 review(s) available for sc 53116 and mosapride
| Article | Year |
|---|---|
5-HT4 receptor ligands: applications and new prospects.
Topics: Animals; Benzamides; Benzimidazoles; Benzoates; Binding Sites; Cardiovascular Physiological Phenomena; Central Nervous System; Digestive System Physiological Phenomena; Humans; Indoles; Ketones; Ligands; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
2 other study(ies) available for sc 53116 and mosapride
| Article | Year |
|---|---|
Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Topics: Animals; Antiemetics; Azepines; Brain; Crystallography, X-Ray; Dogs; Dopamine Antagonists; Ferrets; In Vitro Techniques; Models, Molecular; Pyridines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship | 2003 |
Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.
Topics: Animals; Benzamides; Benzimidazoles; Blood Glucose; Cisapride; Diabetes Mellitus, Experimental; Gastric Emptying; Gastrointestinal Motility; Gastroparesis; Granisetron; Male; Morpholines; Ondansetron; Piperidines; Pyrroles; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Vagotomy | 1997 |